Bromide

Bromide

SCHEMBL3792437

CCCCCCCCCCC(C)[N+](C)(C)O.[Br-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 1/20 0.41
SPHK1 Q9NYA1 1/20 0.43
LMNA P02545 1/20 0.43
DNM1 Q05193 5/20 0.41
ACE2 Q9BYF1 1/20 0.39
PSMD14 O00487 2/20 0.39
PLA2G1B P04054 2/20 0.39
MMP2 P08253 2/20 0.39
ATG4B Q9Y4P1 2/20 0.39
HSP90AA1 P07900 1/20 0.39
RAD52 P43351 1/20 0.39
GPR84 Q9NQS5 3/20 0.39
FDPS P14324 3/20 0.39
FFAR1 O14842 1/20 0.39
CA1 P00915 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL4663245 1.00 SPHK1 (0.43) SPHK1LMNADNM1OPRM1ACE2
Bromide SCHEMBL1840434 0.98 SPHK1 (0.42) SPHK1LMNADNM1OPRM1ACE2
SCHEMBL239716 0.98 SPHK1 (0.45) SPHK1LMNAOPRM1ACE2PSMD14
SCHEMBL239692 0.98 SPHK1 (0.45) SPHK1LMNAOPRM1ACE2PSMD14
SCHEMBL1838532 0.98 SPHK1 (0.45) SPHK1LMNAOPRM1ACE2PSMD14
SCHEMBL238534 0.98 SPHK1 (0.45) SPHK1LMNAOPRM1ACE2PSMD14
SCHEMBL15646327 0.98 SPHK1 (0.45) SPHK1LMNAOPRM1ACE2PSMD14
Water SCHEMBL16398739 0.95 SPHK1 (0.43) SPHK1LMNAOPRM1ACE2PSMD14
Hydrochloric Acid SCHEMBL1831241 0.95 SPHK1 (0.43) SPHK1LMNADNM1OPRM1ACE2
Hydrochloric Acid SCHEMBL9864879 0.95 SPHK1 (0.43) SPHK1LMNADNM1OPRM1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809279-B1 PARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR BAXTER INT (US) 2013-05-29 EP claimed
EP-1871345-B1 NANOPARTICULATE ERLOTINIB FORMULATIONS ELAN PHARMA INT LTD (IE) 2012-08-01 EP claimed
EP-1471887-B1 NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER ELAN PHARMA INT LTD (IE) 2010-04-21 EP claimed